For the first time, developing a business plan can be daunting. In our simple guide, we explain the importance of a business plan and just as critical the importance of having a compelling business idea for your business in the first point. We then step by step take you through the eight critical elements of a good business plan and provide you with checklists at the end of each section.
These eight are;
1) Product/ Service - what is it you are offering?
2) The Market and Competition
3) Marketing
4) Business System
5) Organisation and HR
6) Opportunities and Risks
7) Implementation Schedule
8) Your Financial Plan
Presentation on Patentability of Biotech/Pharma by Dr. Kalyan and Ms. VinitaBananaIP Counsels
Presentation on Patentability of Biotech/Pharma by Dr. Kalyan and Ms. Vinita
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414 /24/34
For the first time, developing a business plan can be daunting. In our simple guide, we explain the importance of a business plan and just as critical the importance of having a compelling business idea for your business in the first point. We then step by step take you through the eight critical elements of a good business plan and provide you with checklists at the end of each section.
These eight are;
1) Product/ Service - what is it you are offering?
2) The Market and Competition
3) Marketing
4) Business System
5) Organisation and HR
6) Opportunities and Risks
7) Implementation Schedule
8) Your Financial Plan
Presentation on Patentability of Biotech/Pharma by Dr. Kalyan and Ms. VinitaBananaIP Counsels
Presentation on Patentability of Biotech/Pharma by Dr. Kalyan and Ms. Vinita
Contact Us for Intellectual Property Services
BananaIP Counsels
Regd Office
No.40,3rd Main Road,JC Industrial Estate,
Kanakapura Road,Bangalore – 560 062.
Email: contact@bananaip.com
Telephone: +91-80-26860414 /24/34
How to avoid Random Association Syndrome: Getting value from Big Health Data.Tracy Allison Altman
My presentation at Big Data Science meetup May 25. The Big Picture for Big Health Data. Differences between big health data and others, sources of big health data and uses for it, analytical methods, algorithms/prize competitions, and opportunities for data scientists.
This is my Keynote presentation to Pharma Forum Russia, St. Petersburg, May 23rd, 2013.
It gives an outline of crucial elements in building a new market approach to different markets.
Increased competition from generics, a growing pressure from payers to reduce costs, and a market in which a drug’s success is more closely tied to its performance are transforming the pharmaceutical and life sciences industry. As the healthcare industry transitions from treating existing illnesses to taking steps to prevent illness before it occurs. By leveraging technology and information traditional pharma business is adding value beyond the pill and emphasizing the need of strong partnerships and strategic alliances with the broader ecosystem
Forum on Personalized Medicine: Challenges for the next decadeJoaquin Dopazo
Bioinformatics and Big Data in the era of Personalized Medicine
10th Anniversary Instituto Roche Forum on Personalized Medicine: Challenges for the next decade.
Santiago de Compostela (Spain), September 25th 2014
Genomic Medicine: Personalized Care for Just PenniesHealth Catalyst
In April 2003, the Human Genome Project was completed and scientists gained the ability to read the entire genetic blueprint for human beings. Since that time, the cost of gene sequencing has fallen from $100 million to $1,000. By 2020, the cost is expected to be mere pennies. Using the power of genomes scientists have found genomic defects for more than 5,000 inherited diseases and are on track to uncover 4,000 more. The implications for treatment of disease are also vast. In the future, clinicians will be able to use genomic-powered personalized medicine to treat patients on an individual basis knowing exactly how their genes will react to treatments and what the best course of action will be.
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
La santé numérique, la médecine 4P et les assurancesAlain Tassy
Il y a un consensus sur le fait que la santé numérique et la médecine 4P sont en train de bouleverser les business models des mutuelles et des assurances santé. Bien que le village gaulois soit protégé par une législation très stricte, le système français ne restera pas figé ad vitam aeternam. En particulier, il faut que l’Assurance Maladie Obligatoire, les mutuelles et les assurances se préparent à l’arrivée des services de prévention. Mais où est le retour sur investissement des innovations ?
Personalized medicine involves the prescription of specific therapeutics best suited for an individual based on their genetic or proteomic profile. This talk discusses current approaches in drug discovery/development, the role of genetics in drug metabolism, and lawful/ethical issues surrounding the deployment of new health technology.
Developing Metrics and KPI (Key Performance IndicatorsVictor Holman
Get a FREE performance management kit and access to all of Victor's full videos at:
www.lifecycle-performance-pros.com
This presentation covers the basics of developing successful performance metrics, from developing winning KPIs, learning how to develop the right metrics, the rules of developing KPIs and metrics and common performance metrics for managing a successful organization.
How to avoid Random Association Syndrome: Getting value from Big Health Data.Tracy Allison Altman
My presentation at Big Data Science meetup May 25. The Big Picture for Big Health Data. Differences between big health data and others, sources of big health data and uses for it, analytical methods, algorithms/prize competitions, and opportunities for data scientists.
This is my Keynote presentation to Pharma Forum Russia, St. Petersburg, May 23rd, 2013.
It gives an outline of crucial elements in building a new market approach to different markets.
Increased competition from generics, a growing pressure from payers to reduce costs, and a market in which a drug’s success is more closely tied to its performance are transforming the pharmaceutical and life sciences industry. As the healthcare industry transitions from treating existing illnesses to taking steps to prevent illness before it occurs. By leveraging technology and information traditional pharma business is adding value beyond the pill and emphasizing the need of strong partnerships and strategic alliances with the broader ecosystem
Forum on Personalized Medicine: Challenges for the next decadeJoaquin Dopazo
Bioinformatics and Big Data in the era of Personalized Medicine
10th Anniversary Instituto Roche Forum on Personalized Medicine: Challenges for the next decade.
Santiago de Compostela (Spain), September 25th 2014
Genomic Medicine: Personalized Care for Just PenniesHealth Catalyst
In April 2003, the Human Genome Project was completed and scientists gained the ability to read the entire genetic blueprint for human beings. Since that time, the cost of gene sequencing has fallen from $100 million to $1,000. By 2020, the cost is expected to be mere pennies. Using the power of genomes scientists have found genomic defects for more than 5,000 inherited diseases and are on track to uncover 4,000 more. The implications for treatment of disease are also vast. In the future, clinicians will be able to use genomic-powered personalized medicine to treat patients on an individual basis knowing exactly how their genes will react to treatments and what the best course of action will be.
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
La santé numérique, la médecine 4P et les assurancesAlain Tassy
Il y a un consensus sur le fait que la santé numérique et la médecine 4P sont en train de bouleverser les business models des mutuelles et des assurances santé. Bien que le village gaulois soit protégé par une législation très stricte, le système français ne restera pas figé ad vitam aeternam. En particulier, il faut que l’Assurance Maladie Obligatoire, les mutuelles et les assurances se préparent à l’arrivée des services de prévention. Mais où est le retour sur investissement des innovations ?
Personalized medicine involves the prescription of specific therapeutics best suited for an individual based on their genetic or proteomic profile. This talk discusses current approaches in drug discovery/development, the role of genetics in drug metabolism, and lawful/ethical issues surrounding the deployment of new health technology.
Developing Metrics and KPI (Key Performance IndicatorsVictor Holman
Get a FREE performance management kit and access to all of Victor's full videos at:
www.lifecycle-performance-pros.com
This presentation covers the basics of developing successful performance metrics, from developing winning KPIs, learning how to develop the right metrics, the rules of developing KPIs and metrics and common performance metrics for managing a successful organization.
www.trinityp3.com
Introducing TrinityP3
• In 2000, Darren Woolley, a scientist and advertising creative director, founded TrinityP3 in Australia. His purpose was to help people to achieve commercial purpose through creative process. People, Purpose, Process – the ‘3P’s’ of TrinityP3.
• Sixteen years on, we’ve grown significantly, in size and in scope. We are Asia Pacific’s leading strategic marketing management consultancy with an international network of industry professionals, consulting at the leading edge of decision making in the marketing and advertising industry.
• Our aim is simple. We want to improve the marketing output of every single organisation that engages us.
• Generating improvement can mean challenging the norm and changing values within a marketing team or broader organisation. We guide our clients on this journey, emerging in a better place for the marketing team and its attributable effect on the organisation.
• We have built significant proprietary IP over the last sixteen years, including sophisticated agency search functionality, detailed financial benchmarking capability, extensive contractual experience and app or web-based evaluation tools.
• Our client base includes more than 50 of the world’s top 100 advertisers. We continue to grow in experience, geographical footprint and expertise. We continue to challenge thinking – our own, and that of our clients.
• Our consultants all possess at least ten years of experience in a specialised field within marketing and procurement.
• We enjoy a high profile in the Australian market and have produced extensive industry material in the form of articles, blog posts, webinars, speaking engagements and opinion pieces. To see the extent of our work in this area, please visit http://www.trinityp3.com/blog/.
ROI Definitions
Typically, TrinityP3 adds value in a pitch process by ensuring the following:
1. That the needs of marketing and advertising are clearly articulated and fulfilled by the process.
2. That the process meets the highest standards of due diligence and corporate governance.
3. That the principles of procurement and marketing are accommodated in the process to achieve the best outcome for both the client and the suppliers.
We flex within the requirements of specific clients as much as possible, within scope; no two processes are exactly alike.
For clarity, we have split the definition of ROI into three components.
Financial ROI: Optimal Efficiency, Optimal Effectiveness.
Operational ROI: Refined Process, Refined Delivery.
Post-Project ROI: The Benefits of a Productive Agency Relationship.
BIO 2014 Business Dev Fundamentals Course_Strategic Alliances_MWYoung 140620 Michael W. Young
Biotechnology Industry Organization 2014 Annual Conference - Business Development Fundamentals Course_Strategic Alliances Module.
FACULTY: Michael W. Young, Principal, biomedwoRx: Life Sciences Consulting LLC.
www.biomedwoRx.com
Aagami Technology Licensing PresentationAagami, Inc.
Aagami, Inc., is a life sciences consulting firm offering,
· Technology Licensing
· Strategic Consulting
· Market Intelligence
For Global companies in
· Technology Licensing Office of Universities
· Medical Devices & Technology
· Pharma
· Biotech
· Consumer Healthcare
· CROs, CDMOs
In Brief, Aagami Brings:
· Deep Experience of overcoming business and socio-cultural differences of various countries
· Extensive ‘C’ level network nurtured for over 15 years
· Global Deal making skills, honed for decades
· Partners having combined experience of 250+ years
· Supplementing your bandwidth to save time, effort & cost
75+ Bio Pharma clients globally across 125+ assignments have put their trust in Aagami since 2003.
Hello Friends,
This slide will help you to under stand the job roles and responsibilities of project manager at Infosys, skills, and competencies required. and marketing manager roles and responsibilities at hul, what knowledge experience required.
It’s one thing to sell to customers—it’s another to negotiate with business partners, corporate lawyers and investors. In this Entrepreneurship 101 lecture, we discuss the art of the sale in depth and give tips and tricks on how you can succeed when negotiating with various stakeholders.
Key topics covered: Partnerships, corporate agreements and negotiating.